Quick Answer
Nutex Health Inc. reported R&D Expense of $285.9 thousand for fiscal year 2021.
Nutex Health Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2021 | $285.9K | -48.7% |
| 2020 | $557.3K | -27.5% |
| 2019 | $768.1K | +40.9% |
| 2018 | $545.2K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2022 | $73.8K | -3.9% | +2.1% |
| September 30, 2021 | $72.3K | -2.1% | +21.2% |
| June 30, 2021 | $59.6K | -81.0% | -22.3% |
| March 31, 2021 | $76.7K | -33.2% | +3.9% |
| September 30, 2020 | $73.8K | -31.5% | -76.5% |
| June 30, 2020 | $314.3K | — | +173.6% |
| March 31, 2020 | $114.9K | -36.6% | +6.6% |
| September 30, 2019 | $107.8K | — | -40.5% |
- Nutex Health Inc. showed a decrease of -48.7% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2021 period, Nutex Health Inc.’s r&d expense has declined by 47.6% (from $545.2 thousand to $285.9 thousand).
- The most recent figure is from Nutex Health Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 31, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: